Ionis Pharmaceuticals, Inc - Strategy, SWOT and Corporate Finance Report
Summary
Ionis Pharmaceuticals, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Ionis Pharmaceuticals, Inc. (Ionis or ‘the company’) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer’s, and Parkinson’s disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington’s disease. Ionis uses antisense technology in the development of its drugs. The company primarily operates in the US. The company is headquartered in Carlsbad, California, the US.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook